Axogen, Inc. (AXGN) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, everyone. Joining me on today's call is Michael Dale, Axogen's President and Chief Executive Officer and Lindsay Hartley, Chief Financial Officer. Michael will discuss second quarter twenty twenty six results and corporate highlights. Lindsay will then provide details on financial performance and overall outlook for the year. This will be followed by a question and answer session. Call and presentation is being broadcast live via webcast, which is available on the Investors section of Axogen's website. Following the end of the live call, a replay will be available on the Investors section of the company's website at www.axogeninc.com. Before we begin, I would like to remind you that during this conference call, management will be making forward looking statements. Forward looking statements include statements regarding financial guidance and outlook, clinical development and regulatory efforts, commercial growth initiatives, reimbursement and market access efforts, training and education initiatives, research and development activities and overall business strategy and performance. These forward looking statements are subject to risks and uncertainties that could cause actual results to differ materially, including without limitation, the risks and uncertainties reflected in the company's filings with the Securities and Exchange Commission, including the most recent annual report on Form 10 ks, subsequent quarterly reports on Form 10 Q and other filings made with the Securities and Exchange Commission. Forward looking statements speak only as of the day they are made, and the company undertakes no obligation to update any forward looking statements, except as required by law. In addition, for a reconciliation of non GAAP measures, please refer to today'...